Literature DB >> 21146629

In vitro models for human skin disease.

Lydia Semlin1, Monika Schäfer-Korting, Claudia Borelli, Hans C Korting.   

Abstract

Modern tissue culture technology has made it possible to generate human skin equivalents that represent either epidermis or epidermis plus dermis (full-thickness skin) in vitro. Commercially available skin equivalents and in-house models are used for safety analysis of cosmetics and toxicity screening of various pharmaceutical compounds. Recently, tissue culture technology has also been used to develop in vitro models of skin disease, in particular to promote cutaneous drug research while sparing experimental animals. The spectrum of model diseases available covers a range from inflammatory disease to cancer. It has, thus, been possible to gain more insight into the role of active pharmaceutical ingredients of various dermatologically relevant drug classes as well as conventional and innovative formulations.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21146629     DOI: 10.1016/j.drudis.2010.12.001

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  11 in total

1.  Design and fabrication of human skin by three-dimensional bioprinting.

Authors:  Vivian Lee; Gurtej Singh; John P Trasatti; Chris Bjornsson; Xiawei Xu; Thanh Nga Tran; Seung-Schik Yoo; Guohao Dai; Pankaj Karande
Journal:  Tissue Eng Part C Methods       Date:  2013-12-31       Impact factor: 3.056

Review 2.  Engineered Skin Tissue Equivalents for Product Evaluation and Therapeutic Applications.

Authors:  Sana Suhail; Naseem Sardashti; Devina Jaiswal; Swetha Rudraiah; Manoj Misra; Sangamesh G Kumbar
Journal:  Biotechnol J       Date:  2019-05-17       Impact factor: 4.677

Review 3.  Building a microphysiological skin model from induced pluripotent stem cells.

Authors:  Zongyou Guo; Claire A Higgins; Brian M Gillette; Munenari Itoh; Noriko Umegaki; Karl Gledhill; Samuel K Sia; Angela M Christiano
Journal:  Stem Cell Res Ther       Date:  2013-12-20       Impact factor: 6.832

4.  Functional testing of topical skin formulations using an optimised ex vivo skin organ culture model.

Authors:  G P Sidgwick; D McGeorge; A Bayat
Journal:  Arch Dermatol Res       Date:  2016-04-16       Impact factor: 3.017

Review 5.  Ethics of animal research in human disease remediation, its institutional teaching; and alternatives to animal experimentation.

Authors:  Rajkumar Cheluvappa; Paul Scowen; Rajaraman Eri
Journal:  Pharmacol Res Perspect       Date:  2017-08

6.  Kinetic Cytokine Secretion Profile of LPS-Induced Inflammation in the Human Skin Organ Culture.

Authors:  Raanan Gvirtz; Navit Ogen-Shtern; Guy Cohen
Journal:  Pharmaceutics       Date:  2020-03-25       Impact factor: 6.321

7.  Polysaccharide-Based Bioink Formulation for 3D Bioprinting of an In Vitro Model of the Human Dermis.

Authors:  Tanja Zidarič; Marko Milojević; Lidija Gradišnik; Karin Stana Kleinschek; Uroš Maver; Tina Maver
Journal:  Nanomaterials (Basel)       Date:  2020-04-11       Impact factor: 5.076

8.  Medaka (Oryzias latipes) Embryo as a Model for the Screening of Compounds That Counteract the Damage Induced by Ultraviolet and High-Energy Visible Light.

Authors:  Marián Merino; José Luis Mullor; Ana Virginia Sánchez-Sánchez
Journal:  Int J Mol Sci       Date:  2020-08-11       Impact factor: 5.923

9.  Serine Protease-Mediated Cutaneous Inflammation: Characterization of an Ex Vivo Skin Model for the Assessment of Dexamethasone-Loaded Core Multishell-Nanocarriers.

Authors:  Janna Frombach; Fiorenza Rancan; Katharina Kübrich; Fabian Schumacher; Michael Unbehauen; Ulrike Blume-Peytavi; Rainer Haag; Burkhard Kleuser; Robert Sabat; Kerstin Wolk; Annika Vogt
Journal:  Pharmaceutics       Date:  2020-09-10       Impact factor: 6.321

10.  A novel renal epithelial cell in vitro assay to assess Candida albicans virulence.

Authors:  Edina K Szabo; Donna M Maccallum
Journal:  Virulence       Date:  2013-11-13       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.